Personalized Medicine Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Personalized Medicine stocks.

Personalized Medicine Stocks Recent News

Date Stock Title
May 9 OSUR Q1 2024 OraSure Technologies Inc Earnings Call
May 9 MYGN Myriad Genetics First Quarter 2024 Earnings: Beats Expectations
May 9 OSUR OraSure Technologies Inc (OSUR) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
May 9 OSUR OraSure Technologies, Inc. (OSUR) Q1 2024 Earnings Call Transcript
May 8 OSUR OraSure Technologies (OSUR) Q1 Earnings Meet Estimates
May 8 OSUR OraSure Technologies Non-GAAP EPS of $0.04 beats by $0.01, revenue of $54.13M beats by $1.86M
May 8 MYGN Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2024 Earnings Call Transcript
May 8 OSUR OraSure Reports Q1 ’24 Revenue of $54.1 Million
May 8 MYGN Myriad Genetics (MYGN) Posts Narrower-Than-Estimate Loss in Q1
May 8 MYGN Myriad Genetics surges 17% as Street applauds 2024 guidance, Q1 results
May 8 MYGN Myriad Genetics Inc (MYGN) Q1 2024 Earnings Call Transcript Highlights: Strong Start with ...
May 8 MYGN Myriad Genetics, Inc. (MYGN) Q1 2024 Earnings Call Transcript
May 7 MYGN Myriad (MYGN) Reports Q1 Earnings: What Key Metrics Have to Say
May 7 MYGN Myriad Genetics Reports Q1 2024 Earnings: Revenue Growth Surpasses Estimates Amidst Challenges
May 7 MYGN Myriad Genetics (MYGN) Reports Q1 Loss, Tops Revenue Estimates
May 7 MYGN Myriad Genetics GAAP EPS of -$0.29 beats by $0.01, revenue of $202.2M beats by $8.95M
May 7 MYGN Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDA
May 7 OSUR OraSure Technologies Q1 2024 Earnings Preview
May 7 MYGN Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business
May 7 MYGN Myriad Genetics (NASDAQ:MYGN) shareholders have endured a 26% loss from investing in the stock five years ago
Personalized Medicine

Personalized medicine, precision medicine, or theranostics is a medical model that separates people into different groups—with medical decisions, practices, interventions and/or products being tailored to the individual patient based on their predicted response or risk of disease. The terms personalized medicine, precision medicine, stratified medicine and P4 medicine are used interchangeably to describe this concept though some authors and organisations use these expressions separately to indicate particular nuances.While the tailoring of treatment to patients dates back at least to the time of Hippocrates, the term has risen in usage in recent years given the growth of new diagnostic and informatics approaches that provide understanding of the molecular basis of disease, particularly genomics. This provides a clear evidence base on which to stratify (group) related patients.

Browse All Tags